New COVID-19 Antiviral Drug Remdesivir Offers ‘No Significant’ Benefit, More Research Needed-Study

The first randomised trial for a promising new antiviral drug, lauded by many as a positive treatment for SARS-CoV-2 patients, suggested that there were no significant clinical benefits, with researchers urging further trials, a study released on late Wednesday revealed.…